Sionna Therapeutics (SION) Current Leases (2024 - 2026)
Sionna Therapeutics (SION) posted Current Leases of $1.3 million for Q1 2026, up 4.18% sequentially from $1.3 million in Q4 2025, and up 18.14% YoY from $1.1 million in Q1 2025.
Sionna Therapeutics (SION) Current Leases (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Current Leases for 3 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Current Leases rose 18.14% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 18.14% YoY) and the FY2025 annual result came in at $1.3 million, up 18.38% from the prior year.
- Current Leases advanced to $1.3 million in Q1 2026 per SION's latest filing, from $1.3 million in the prior quarter.
- Over five years, Current Leases peaked at $1.3 million in Q1 2026 and troughed at $1.1 million in Q4 2024.
- A 3-year average of $1.2 million and a median of $1.2 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases grew 18.38% in 2025, then rose 18.14% in 2026.
- Over 3 years, Current Leases stood at $1.1 million in 2024, then climbed by 18.38% to $1.3 million in 2025, then climbed by 4.18% to $1.3 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.3 million, $1.3 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.07 Mn |